secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tilray Brands, Inc. (TLRY)
CIK:        0001731348
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001140361-23-046812
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tilray acquires Ontario subsidiary from MediPharm for 1.37M shares; converts $50M note into 1.03M shares
--------------------------------------------------------------------------------

- Acquired all shares of 1000652011 Ontario Inc. from MediPharm Labs for 1,371,157 Tilray shares; earn-out up to 1,378,843 more if VWAP below $2.3958 by Oct 9, 2023.
- Issued 1,032,616 Tilray shares to HT Investments MA LLC upon conversion of $50M convertible note dated July 12, 2022.
- Both share issuances are unregistered: Regulation S for MediPharm, Section 3(a)(9) for HTI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1731348/000114036123046812/0001140361-23-046812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1731348/000114036123046812/ef20011830_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-046812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer